The medulloblastoma drug pipeline analysis highlights ongoing advancements in the treatment of this aggressive pediatric brain tumor, which originates in the cerebellum and can spread through cerebrospinal fluid. With a rising focus on molecular subgroups, personalized therapies, and innovative drug candidates, the pipeline landscape is evolving to meet the urgent clinical need and im... https://www.expertmarketresearch.com/clinical-trials/medulloblastoma-drug-pipeline-insight